LTR Pharma Limited – 2026 Corporate Governance Statement LTR Pharma Limited ACN 644 924 569 Corporate governance statement This statement was approved by the Board on 28 August 2026 Overview As an ASX listed company, LTR Pharma Limited ACN 103 087 449 ( LTR Pharma or...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from LTR Pharma
- Appendix 4E and Annual Report to Shareholders
- SPONTAN Real-World Study Reports 93% Response
- Quarterly Activities/Appendix 4C Cash Flow Report
- LTR Executes U.S. Commercial Agreement with Strive
- LTR Executes Definitive U.S. Commercial Agreement with Shed
Later from LTR Pharma
- FY26 Results Announcement
- LTR Expands Men's Health Portfolio with KYZATREX Pilot
- Investor Presentation
- Application for quotation of securities - LTP
- Notice of Annual General Meeting/Proxy Form
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma